Genpact (NYSE:G – Get Free Report) issued an update on its fourth quarter 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 0.930-0.940 for the period, compared to the consensus earnings per share estimate of 0.890. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion. Genpact also updated its FY 2025 guidance to 3.600-3.610 EPS.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on G shares. Needham & Company LLC raised their price target on Genpact from $50.00 to $53.00 and gave the stock a “buy” rating in a research note on Friday, August 8th. Citigroup raised shares of Genpact to a “hold” rating in a research report on Thursday, October 23rd. Wall Street Zen cut shares of Genpact from a “buy” rating to a “hold” rating in a research note on Friday, September 5th. JPMorgan Chase & Co. dropped their price target on shares of Genpact from $55.00 to $50.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 20th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Genpact in a report on Wednesday, October 8th. Three investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $51.13.
Check Out Our Latest Report on Genpact
Genpact Stock Performance
Genpact (NYSE:G – Get Free Report) last issued its quarterly earnings results on Thursday, November 6th. The business services provider reported $0.97 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.07. Genpact had a net margin of 11.01% and a return on equity of 22.71%. The firm had revenue of $1.29 billion during the quarter, compared to the consensus estimate of $1.27 billion. During the same period in the prior year, the firm earned $0.85 EPS. The business’s revenue was up 6.6% on a year-over-year basis. Genpact has set its FY 2025 guidance at 3.600-3.610 EPS. Q4 2025 guidance at 0.930-0.940 EPS. On average, research analysts anticipate that Genpact will post 3.21 EPS for the current fiscal year.
Genpact Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 23rd. Investors of record on Tuesday, December 9th will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, December 9th. This represents a $0.68 dividend on an annualized basis and a yield of 1.5%. Genpact’s dividend payout ratio (DPR) is 22.59%.
Insider Activity
In other news, CEO Balkrishan Kalra sold 55,000 shares of the business’s stock in a transaction that occurred on Thursday, September 11th. The stock was sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the sale, the chief executive officer directly owned 295,246 shares in the company, valued at approximately $12,801,866.56. The trade was a 15.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Piyush Mehta sold 76,902 shares of the company’s stock in a transaction on Friday, September 12th. The shares were sold at an average price of $42.58, for a total value of $3,274,487.16. Following the completion of the transaction, the senior vice president owned 134,880 shares of the company’s stock, valued at $5,743,190.40. The trade was a 36.31% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 3.07% of the company’s stock.
Institutional Trading of Genpact
Several institutional investors have recently made changes to their positions in the business. Merit Financial Group LLC bought a new stake in Genpact in the third quarter valued at about $317,000. WealthCollab LLC lifted its stake in Genpact by 19.6% during the second quarter. WealthCollab LLC now owns 3,167 shares of the business services provider’s stock worth $139,000 after purchasing an additional 519 shares during the period. Captrust Financial Advisors boosted its holdings in Genpact by 57.5% during the second quarter. Captrust Financial Advisors now owns 8,882 shares of the business services provider’s stock valued at $391,000 after purchasing an additional 3,243 shares in the last quarter. Vident Advisory LLC acquired a new stake in Genpact during the second quarter valued at approximately $216,000. Finally, Shay Capital LLC bought a new stake in shares of Genpact in the 2nd quarter valued at approximately $506,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Genpact Company Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Stories
- Five stocks we like better than Genpact
- Why Are These Companies Considered Blue Chips?
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
- What is the Euro STOXX 50 Index?
- Qualcomm Earnings Surprise Wall Street—Here’s What Q4 Could Deliver
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
